Correlation Between Duopharma Biotech and Bonia Bhd

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Bonia Bhd at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Bonia Bhd into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and Bonia Bhd, you can compare the effects of market volatilities on Duopharma Biotech and Bonia Bhd and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Bonia Bhd. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Bonia Bhd.

Diversification Opportunities for Duopharma Biotech and Bonia Bhd

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Duopharma and Bonia is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Bonia Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bonia Bhd and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Bonia Bhd. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bonia Bhd has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Bonia Bhd go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Bonia Bhd

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to generate 0.9 times more return on investment than Bonia Bhd. However, Duopharma Biotech Bhd is 1.11 times less risky than Bonia Bhd. It trades about -0.09 of its potential returns per unit of risk. Bonia Bhd is currently generating about -0.09 per unit of risk. If you would invest  129.00  in Duopharma Biotech Bhd on August 30, 2024 and sell it today you would lose (3.00) from holding Duopharma Biotech Bhd or give up 2.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  Bonia Bhd

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Bonia Bhd 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bonia Bhd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Duopharma Biotech and Bonia Bhd Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and Bonia Bhd

The main advantage of trading using opposite Duopharma Biotech and Bonia Bhd positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Bonia Bhd can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bonia Bhd will offset losses from the drop in Bonia Bhd's long position.
The idea behind Duopharma Biotech Bhd and Bonia Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bonds Directory
Find actively traded corporate debentures issued by US companies